Patterns of disease activity in systemic lupus erythematosus

Arthritis and Rheumatism

Volumn 42, Issue 12, 1999, Pages 2682-2688

  Barr, Susan G ^a   Zonana Nacach, Abraham ^a   Magder, Laurence S ^b   Petri, Michelle ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; DISEASE ACTIVITY; DISEASE CLASSIFICATION; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RELAPSE; REMISSION; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX;

EID: 0033513312     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199912)42:12<2682::AID-ANR26>3.0.CO;2-6     Document Type: Article

References (25)

1. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH, and the Committee on Prognosis Studies in SLE. Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum 1992;35:630-40.
2. Liang MH, Socher SA, Larson MG, Schur PH. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum 1989;32:1107-18.
3. Symmons DP, Coppock JS, Bacon PA, Bresnihan B, Isenberg DA, Maddison P, et al. Development and assessment of a computerized index of clinical disease activity in systemic lupus erythematosus. QJM 1988;69:927-37.
4. Gladman D, Ginzler E, Goldsmith C, Fortin P, Liang M, Urowitz M, et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index for systemic lupus erythematosus. Arthritis Rheum 1996;39:363-9.
5. Nossent JC. Course and prognostic value of systemic lupus erythematosus disease activity index in black Caribbean patients. Semin Arthritis Rheum 1993;23:16-21.
6. Drenkard C, Villa AR, García-Padilla C, Pérez-Vázquez ME, Alarcón-Segovia D. Remission of systemic lupus erythematosus. Medicine (Baltimore) 1996;75:88-98.
7. Nossent JC. SLICC/ACR damage index in Afro-Caribbean patients with systemic lupus erythematosus: changes in and relationship to disease activity, corticosteroid therapy and prognosis. J Rheumatol 1998;25:654-9.
8. Petri M, Genovese M, Engle E, Hochberg MC. Definition, incidence, and clinical description of flare in systemic lupus erythematosus: a prospective cohort study. Arthritis Rheum 1991;34:937-44.
9. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
10. Liang MH, Socher SA, Roberts WN, Esdaile JM. Measurement of systemic lupus erythematosus activity in clinical research. Arthritis Rheum 1988;31:817-25.
11. Gladman DD, Goldsmith CH, Urowitz MB, Bacon P, Bombardier C, Isenberg DA, et al. Crosscultural validation and reliability of 3 disease activity indices in systemic lupus erythematosus. J Rheumatol 1992;19:608-11.
12. Altman DG. Some common problems in medical research. In: Practical statistics for medical research. New York: Chapman & Hall; 1991. p. 396-439.
13. Zwick R. Another look al interrater agreement. Psychol Bull 1988;103:374-8.
14. Byrt T, Bishop J, Carlin JB. Bias, prevalence and kappa. J Clin Epidemiol 1993;46:423-9.
15. Cicchetti DV, Feinstein AR. High agreement but low kappa. II. Resolving the paradoxes. J Clin Epidemiol 1990;43:551-8.
16. Ropes MW. Observations on the natural course of disseminated lupus erythematosus. Medicine (Baltimore) 1964;43:387-91.
17. Dubois EL. Systemic lupus erythematosus: recent advances in its diagnosis and treatment. Ann Intern Med 1956;45:163-84.
18. Tumulty PA. The clinical course of systemic lupus erythematosus. JAMA 1954;156:947-53.
19. Tozman ECS, Urowitz MB, Gladman DD. Prolonged complete remission in previously severe SLE. Ann Rheum Dis 1982;41:39-40.
20. Heller CA, Schur PH. Serological and clinical remission in systemic lupus erythematosus. J Rheumatol 1985;12:916-8.
21. Walz LeBlanc BAE, Gladman DD, Urowitz MB. Serologically active clinically quiescent systemic lupus erythematosus - predictors of clinical flares. J Rheumatol 1994;21:2239-41.
22. Gladman DD, Goldsmith CH, Urowitz MB, Bacon P, Bombardier C, Isenberg DA, et al. Sensitivity to change of 3 systemic lupus erythematosus disease activity indices: international validation. J Rheumatol 1994;21:1468-71.
23. Petri M, Hellmann D, Hochberg MC. Validity and reliability of lupus activity measures in the routine clinic setting. J Rheumatol 1992;19:53-9.
24. Hawker G, Gabriel S, Bombardier C, Goldsmith C, Caron D, Gladman D. A reliability study of SLEDAI: a disease activity index for systemic lupus erythematosus. J Rheumatol 1993;20:657-60.
25. Bombardieri S, Vitali C, Caponi L, Manca L, Bencivelli W. Activity criteria in systemic lupus erythematosus. Clin Exp Rheumatol 1994;12:S45-8.